Short Biography
Kevin Carleton is the founder of Nottle Rock Scientific Consulting with more than two decades of experience supporting pharmaceutical and biotechnology drug development programs. His expertise spans both small molecule and large molecule bioanalytical strategies, including method development, validation, sample analysis, and the application of fit-for-purpose approaches across all phases of development. Throughout his career, he has provided scientific leadership for complex bioanalytical programs while helping organizations navigate evolving regulatory expectations. Kevin has extensive experience interacting with global health authorities, preparing regulatory submissions, responding to agency questions, and supporting successful inspections and approvals. He is recognized for translating complex scientific challenges into practical, compliant solutions that accelerate drug development while maintaining the highest standards of scientific quality. Through Nottle Rock Scientific Consulting, Kevin partners with clients to deliver strategic, science-driven solutions tailored to their unique development needs.
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Regulatory Strategy
Health Authority Interactions
Scientific Leadership
Due Diligence